Cheminformatics

Site4Drug: Predicting Drug-Binding Target Sites with an AI Agent

Taehan Kim, Sarrah Rose Mikhail Leung, Bharat Mekala, Jeongbin Park

Featured June 18, 2026

This analysis was generated by SciGrove. Upload your own PDFs or enter a DOI — and get the same AI breakdown on any paper.

Get started

AI-generated analysis — This is SciGrove's AI interpretation of the paper, not peer-reviewed content. Always refer to the original paper.

Simply

Site4Drug acts as an intelligent assistant that scans protein sequences to pinpoint the best spots for drugs to attach, providing clear reasoning and safety warnings to help scientists design better therapies.

In depth

The paper introduces Site4Drug, an agentic system that reframes protein target-site selection as a constraint-first decision problem. By integrating diverse sequence-based evidence—such as topology, post-translational modifications, and motif context—the system generates ranked, auditable candidate regions for both small-molecule pockets and antibody epitopes.

Key Takeaways

1
The system utilizes a constraint-first discovery pipeline to identify targetable protein regions without requiring explicit structural input.
2
It provides auditable decision logs and risk flags, allowing researchers to debug site-selection choices and understand potential failure modes.
3
The framework demonstrates competitive performance against structure-based baselines while enabling modality-aware design handoffs for downstream therapeutic development.

Conceptual Flow

HIGH LEVEL

Methodology

The system gathers clues about a protein's shape and features to decide where a drug could best attach.

Protein Sequence

Evidence Data

Analyze and Rank

Targetable Sites

Results

The system successfully finds drug sites as well as older methods, but with added explanations for why each site was chosen.

Raw Sequence

Old Methods

Outperform and Explain

Validated Drug Sites